XML 71 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity
12 Months Ended
Dec. 31, 2012
Equity  
Equity

Note 7—Equity

 

Stock-Based Compensation:

 

In May 2009, the Company adopted the 2009 Stock Purchase and Option Plan (the “2009 Option Plan”) for Key Employees of the Company and its subsidiaries.  The Company currently also maintains the 2000 Stock Purchase and Option Plan (the “2000 Option Plan”).  No additional options can be granted under the 2000 Option Plan.  The 2009 Option Plan authorizes the granting of additional stock options by a committee of the Company’s Board of Directors. As of December 31, 2012, there were 4,970,270 shares of common stock available for the granting of additional stock options under the 2009 Option Plan. Options granted under the 2000 Option Plan and the 2009 Option Plan vest ratably over a period of five years and are exercisable over a period of ten years from the date of grant.

 

In 2004, the Company adopted the 2004 Stock Option Plan for Directors of Amphenol Corporation (the “Directors Option Plan”). The Directors Option Plan is administered by the Company’s Board of Directors.  As of December 31, 2012, the maximum number of shares of common stock available for the granting of additional stock options under the Directors Option Plan was 70,000, although no additional options are expected to be granted under this plan.  Options granted under the Directors Option Plan vest ratably over a period of three years and are exercisable over a period of ten years from the date of grant.

 

In May 2012, the Company adopted the 2012 Restricted Stock Plan for Directors of Amphenol Corporation (the “Restricted Stock Plan”). The Restricted Stock Plan is administered by the Company’s Board of Directors.  As of December 31, 2012, the maximum number of restricted shares available for future grants under the Restricted Stock Plan was 108,571.  Restricted shares granted under the Restricted Stock Plan generally vest on the first anniversary of the grant date.  Grants under the Restricted Stock Plan entitle the holder to receive shares of the Company’s common stock without payment.

 

The grant-date fair value of each option grant under the 2000 Option Plan, the 2009 Option Plan and the Directors Option Plan is estimated using the Black-Scholes option pricing model. The grant-date fair value of each restricted share grant is determined based on the closing share price of the Company’s stock on the date of the grant. The fair value is then amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. Use of a valuation model for option grants requires management to make certain assumptions with respect to selected model inputs. Expected share price volatility was calculated based on the historical volatility of the common stock of the Company and implied volatility derived from related exchange traded options. The average expected life was based on the contractual term of the option and expected employee exercise and historical post-vesting employment termination experience. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected life assumed at the date of grant. The expected annual dividend per share is based on the Company’s dividend rate.

 

Stock Options

 

Stock option activity for 2010, 2011 and 2012 was as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Weighted

 

Remaining

 

Aggregate

 

 

 

 

 

Average

 

Contractual

 

Intrinsic

 

 

 

Options

 

Exercise Price

 

Term (in years)

 

Value

 

 

 

 

 

 

 

 

 

 

 

Options outstanding at January 1, 2010

 

12,704,303

 

$

29.58

 

7.16

 

 

 

Options granted

 

2,602,500

 

43.00

 

 

 

 

 

Options exercised

 

(2,331,429

)

19.99

 

 

 

 

 

Options forfeited

 

(269,050

)

37.18

 

 

 

 

 

Options outstanding at December 31, 2010

 

12,706,324

 

33.93

 

7.18

 

 

 

Options granted

 

2,551,350

 

53.45

 

 

 

 

 

Options exercised

 

(1,037,674

)

25.14

 

 

 

 

 

Options forfeited

 

(203,100

)

39.75

 

 

 

 

 

Options outstanding at December 31, 2011

 

14,016,900

 

38.00

 

6.89

 

 

 

Options granted

 

2,990,000

 

53.31

 

 

 

 

 

Options exercised

 

(3,252,961

)

29.33

 

 

 

 

 

Options forfeited

 

(307,220

)

42.84

 

 

 

 

 

Options outstanding at December 31, 2012

 

13,446,719

 

43.39

 

7.08

 

$

286,596

 

Vested and non-vested expected to vest at December 31, 2012

 

12,329,575

 

43.01

 

6.98

 

$

267,483

 

Exercisable at December 31, 2012

 

5,495,542

 

$

37.02

 

5.55

 

$

152,103

 

 

A summary of the status of the Company’s non-vested options as of December 31, 2012 and changes during the year then ended is as follows:

 

 

 

Options

 

Weighted Average Fair
Value at Grant Date

 

 

 

 

 

 

 

Non-vested options at January 1, 2012

 

7,636,576

 

$

13.41

 

Options granted

 

2,990,000

 

12.96

 

Options vested

 

(2,368,179

)

13.07

 

Options forfeited

 

(307,220

)

13.09

 

Non-vested options at December 31, 2012

 

7,951,177

 

$

13.36

 

 

The weighted-average fair value at the grant date of options granted during 2011 and 2010 was $14.19 and $14.69, respectively.

 

During the years ended December 31, 2012, 2011, and 2010, the following activity occurred under the Company’s option plans:

 

 

 

2012

 

2011

 

2010

 

Total intrinsic value of stock options exercised

 

$

95,891

 

$

29,697

 

$

67,841

 

Total fair value of stock options vested

 

30,964

 

28,563

 

23,714

 

 

On December 31, 2012 the total compensation cost related to non-vested options not yet recognized is approximately $75,901, with a weighted average expected amortization period of 3.24 years.

 

Restricted Shares

 

As of December 31, 2012, the Company has issued 16,429 restricted shares with a weighted-average fair value at grant date of $53.26 per share.  As of December 31, 2012, the total compensation cost related to non-vested restricted shares not yet recognized was approximately $348 with a weighted average expected amortization period of 0.39 years.

 

Stock Repurchase Program:

 

In January 2011, the Company announced that its Board of Directors authorized a stock repurchase program under which the Company could repurchase up to 20,000,000 shares of its common stock during the three year period ending January 31, 2014 (the “2011 Program”). During the twelve months ended December 31, 2012, the Company repurchased 6,571,611 shares of its common stock under the 2011 Program for approximately $380,000.  During the twelve months ended December 31, 2011, the Company repurchased 13,428,389 shares of its common stock for approximately $672,200.  These treasury shares have been retired by the Company and common stock and accumulated earnings were reduced accordingly.  As of December 31, 2012, the Company has repurchased all shares authorized under the 2011 Program.

 

In January 2013, the Company announced that its Board of Directors authorized a stock repurchase program under which the Company may repurchase up to 10,000,000 shares of its common stock during the two year period ending January 31, 2015 (the “2013 Program”). The price and timing of any such purchases under the 2013 Program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, economic and market conditions and stock price.  Through February 15, 2013, the Company has repurchased 743,877 shares of its common stock under the 2013 Program for $50,290.  These treasury shares will be retired by the Company and common stock and accumulated earnings will be reduced accordingly.  At February 15, 2013, approximately 9,256,123 additional shares of common stock may be repurchased under the 2013 Program.

 

Dividends:

 

After declaration by the Board of Directors, the Company paid a quarterly dividend on its common stock of $0.105 per share in 2012 and $0.015 per share in 2011.  Total dividends declared during 2012, 2011 and 2010 were $67,677, $10,097 and $10,449,  respectively. Total dividends paid in 2012 were $70,122, including those declared in 2011 and paid in 2012, total dividends paid in 2011 were $10,282, including those declared in 2010 and paid in 2011, and total dividends paid in 2010 were $10,413, including those declared in 2009 and paid in 2010.

 

Accumulated Other Comprehensive Income (Loss):

 

Balances of related after-tax components comprising accumulated other comprehensive income (loss) included in equity at December 31, 2012, 2011 and 2010 are as follows:

 

 

 

Foreign Currency
Translation
Adjustment

 

Revaluation of
Derivatives

 

Defined Benefit
Plan Liability
Adjustment

 

Accumulated
Other Comprehensive
Income
(Loss)

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2010

 

$

24,141

 

$

(2,363

)

$

(121,868

)

$

(100,090

)

Translation adjustments

 

17,465

 

 

 

17,465

 

Revaluation of interest rate derivatives, net of tax of $1,486

 

 

2,363

 

 

2,363

 

Defined benefit plan liability adjustment, net of tax of $2,639

 

 

 

(4,495

)

(4,495

)

Balance at December 31, 2010

 

41,606

 

 

(126,363

)

(84,757

)

Translation adjustments

 

(10,154

)

 

 

(10,154

)

Revaluation of interest rate derivatives, net of tax of $173

 

 

(287

)

 

(287

)

Defined benefit plan liability adjustment, net of tax of $12,959

 

 

 

(24,859

)

(24,859

)

Balance at December 31, 2011

 

31,452

 

(287

)

(151,222

)

(120,057

)

Translation adjustments

 

25,858

 

 

 

25,858

 

Revaluation of forward contract derivatives, net of tax of $39

 

 

538

 

 

538

 

Defined benefit plan liability adjustment, net of tax of $8,936

 

 

 

(23,343

)

(23,343

)

Balance at December 31, 2012

 

$

57,310

 

$

251

 

$

(174,565

)

$

(117,004

)